90692997 - PACT PHARMA

Information

• Trademark
• 90692997

• Source

• Serial Number

  90692997

• Registration Number

  6629196

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 40 - Treatment of materials
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  May 06, 2021
  3 years ago

• Registration Date

  January 25, 2022
  2 years ago

• Transaction Date

  April 02, 2024
  7 months ago

• Status Date

  February 27, 2024
  8 months ago

• Published for Opposition Date

  November 09, 2021
  3 years ago

• Location Date

  February 27, 2024
  8 months ago

• First Use Anywhere Date

  June 21, 2017
  7 years ago

• First Use In Commerce Date

  June 21, 2017
  7 years ago

• Status Code

  711

• Current Location

  TMO LAW OFFICE 116

  Employee Name

  BENMAMAN, ALICE MEDINA

• Attorney Docket Number

  50180.202084

  Attorney Name

  Cara Baer

  Law Office Assigned Location Code

  M70

• Owners

  • PACT Pharma, Inc.

Case File Statements

• GS0401: Bio-manufacturing for others, namely, manufacturing of adoptive cell and personalized adoptive cell therapies; none of the foregoing for use in connection with patient self-management, pain management or substance misuse
• DM0000: The mark consists of the word PACT in the color white with a line split between the letter T on a background that is an irregular circular shape and 3 colors. The first color closest to the word PACT is dark blue, the center color is light blue, and the last color is green. The word PHARMA is to the right of the irregular circular shape in the color white and lowercase characters. The irregular circular shape is shaped like a T-cell. The black background is not part of the mark.
• GS0051: pharmaceutical preparations and substances for the treatment of genetic diseases, immunological diseases and cancer; personalized cell therapies for medical use for the treatment of cancer; biological preparations for medical purposes, namely, in the field of personalized cell therapies for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; pharmaceuticals, namely, immunotherapies for the treatment of cancer; oncological preparations, namely, pharmaceutical products for the detection and treatment of cancer; biological preparations for the treatment of cancer and oncological conditions; pharmaceutical products for the treatment of cancer and oncological conditions; none of the foregoing for use in connection with patient self-management, pain management or substance misuse
• CC0000: The color(s) White, dark blue, light blue and green is/are claimed as a feature of the mark.
• D10000: "PHARMA"
• GS0421: design of personalized adoptive cell therapies for others; none of the foregoing for use in connection with patient self-management, pain management or substance misuse

Case File Event Statements

• 2/28/2024 - 8 months ago

  20 - NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED Type: NCS7

• 2/27/2024 - 8 months ago

  19 - CANCELLED SECTION 7-TOTAL Type: C7..

• 6/16/2023 - a year ago

  18 - REQUEST FOR SECT 7 TOTAL SURRENDER FILED Type: C7RF

• 2/21/2024 - 8 months ago

  17 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE

• 6/16/2023 - a year ago

  16 - TEAS SECTION 7 SURRENDER RECEIVED Type: ES7S

• 1/25/2022 - 2 years ago

  15 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 11/9/2021 - 3 years ago

  14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 11/9/2021 - 3 years ago

  13 - PUBLISHED FOR OPPOSITION Type: PUBO

• 10/20/2021 - 3 years ago

  12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 10/5/2021 - 3 years ago

  11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 9/29/2021 - 3 years ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 9/28/2021 - 3 years ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 9/28/2021 - 3 years ago

  8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 9/27/2021 - 3 years ago

  7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 9/27/2021 - 3 years ago

  6 - NON-FINAL ACTION E-MAILED Type: GNRT

• 9/27/2021 - 3 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 9/27/2021 - 3 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 8/10/2021 - 3 years ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 8/7/2021 - 3 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 5/10/2021 - 3 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP